An AllTrials project

NCT03541174: A trial that was reported late by Idorsia Pharmaceuticals Ltd.

This trial has reported, although it was 178 days late in doing so.

Full data

Full entry on ClinicalTrials.gov NCT03541174
Title Multi-center, Blinded, Randomized, Parallel-group, Phase 3 Study With Aprocitentan in Subjects With Resistant Hypertension (RHT)
Results Status Reported (late)
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date June 18, 2018
Completion date May 14, 2021
Required reporting date May 14, 2022, midnight
Actual reporting date Nov. 8, 2022
Date last checked at ClinicalTrials.gov Feb. 9, 2024
Days late 178